Moderna says that it’s expanding its messenger RNA (mRNA) vaccine pipeline to include mRNA-1230, a triple-combination respiratory vaccine candidate to protect against COVID-19, influenza and respiratory syncytial virus (RSV), and mRNA-1287, a vaccine candidate that will target four endemic human coronaviruses (HCoVs).
Source: Drug Industry Daily